Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway

Baocheng Hu1, Shuang-Yin Han, Xiang Wang

  • 1Department of Radiation Oncology, Kimmel Cancer Center of Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Insights

The Fragile Histidine Triad (Fhit) gene is often lost in human cancers. Its absence enhances DNA damage checkpoints via the ATR/CHK1 pathway, promoting cancer cell survival and radioresistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • The Fragile Histidine Triad (Fhit) gene is frequently altered in human epithelial tumors, with deletions and reduced expression observed in approximately 70% of cases.
  • While Fhit gene inactivation is linked to tumor progression and Fhit overexpression induces apoptosis, the specific signaling pathways involved remain largely unidentified.

Purpose of the Study:

  • To investigate the role of Fhit gene inactivation in DNA damage response pathways.
  • To determine the impact of Fhit deficiency on cell cycle checkpoints and radioresistance.

Main Methods:

  • Utilized Fhit knockout (Fhit-/-) mouse-derived cells and compared their responses to wild-type counterparts.
  • Analyzed cell cycle checkpoint activation, specifically focusing on the S and G2 phases.
  • Investigated the involvement of the ATR/CHK1 signaling pathway in mediating checkpoint responses.

Main Results:

  • Fhit-/- cells exhibited significantly enhanced S and G2 checkpoint responses compared to wild-type cells.
  • The heightened checkpoint activation in Fhit-/- cells was found to be regulated by the ATR/CHK1 pathway.
  • These enhanced checkpoints contributed to increased radioresistance in Fhit-/- cells, indicating greater survival after DNA damage.

Conclusions:

  • Fhit gene inactivation is associated with augmented DNA damage survival due to overactive ATR/CHK1-regulated checkpoints.
  • The Fhit-dependent DNA damage response pathway may play a crucial role in cancer progression.
  • Targeting the ATR/CHK1 pathway in Fhit-deficient cancers could be a potential therapeutic strategy.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...